About Pelago Bioscience
Pelago Bioscience is a company based in Solna (Sweden) founded in 2013. Pelago Bioscience offers products and services including CETSA Services, Target Discovery, and Lead Optimization. Pelago Bioscience operates in a competitive market with competitors including Anabios, Kiyatec, Cellply, Lucid Scientific and CytoTronics, among others.
- Headquarter Solna, Sweden
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Pelago Bioscience Ab
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
European Union
& 1 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Pelago Bioscience
Pelago Bioscience offers a comprehensive portfolio of products and services, including CETSA Services, Target Discovery, and Lead Optimization.
Technology for assessing cellular target engagement in drug discovery
Services for identifying and validating drug targets
Processes for enhancing drug candidate potency and selectivity
People of Pelago Bioscience
Unlock access to complete
Funding Insights of Pelago Bioscience
Investors in Pelago Bioscience
Pelago Bioscience has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include European Union and Impilo.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Impilo is focused on healthcare investments in Nordic regions.
|
Locked | Locked | Locked | |
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Locked | Locked | Locked |
Investor details for Pelago Bioscience
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Pelago Bioscience
Investment portfolio details for Pelago Bioscience
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Pelago Bioscience
Detailed financials for Pelago Bioscience
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Pelago Bioscience Comparisons
Peer comparison for Pelago Bioscience
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Pelago Bioscience
Pelago Bioscience operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Anabios, Kiyatec, Cellply, Lucid Scientific and CytoTronics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Ex-vivo human tissue studies are performed for preclinical drug discovery.
|
|
| Locked | Locked | Locked |
Kiyatec is focused on revolutionizing cancer care through predictive platforms.
|
|
| Locked | Locked | Locked |
Developer of in-vitro diagnostic products for the detection of cancer
|
|
| Locked | Locked | Locked |
Real-time cell analyzers are developed for oxygen consumption monitoring.
|
|
| Locked | Locked | Locked |
Cell-based assays for drug discovery are developed via CMOS platform.
|
|
| Locked | Locked | Locked |
Develops cell-based assays and provides services for drug discovery and development.
|
Detailed competitors of Pelago Bioscience
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Pelago Bioscience
Complete news archive for Pelago Bioscience
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Pelago Bioscience
Pelago Bioscience was founded in 2013 and raised its 1st funding round 4 years after it was founded.
Pelago Bioscience is headquartered in Solna, Sweden.
Pelago Bioscience was founded in 2013 in Solna, Sweden, and operates within the biotechnology sector focused on drug discovery. Assay services based on Cellular Thermal Shift Assay (CETSA) technology are provided to measure drug-target interactions in situ. These support preclinical and clinical development through three formats: CETSA Classics using western blot detection, CETSA HT with plate-based fluorescence, and CETSA MS enabling mass spectrometry analysis of up to 6000 proteins.
Pelago Bioscience's top competitors include Metrion Biosciences, CytoTronics and Kiyatec.
Pelago Bioscience offers CETSA Services, Target Discovery, and Lead Optimization.
Pelago Bioscience has 2 investors. Key investors include European Union, and Impilo.